Twist Historical Income Statement

Stocks . USA . 
Stock . Twist Bioscience Corp
TWST Stock  USD 46.40  4.17  9.87%   
Historical analysis of Twist Bioscience income statement accounts such as Interest Expense of 27.6 K, Selling General Administrative of 124.4 M, Total Revenue of 328.6 M or Gross Profit of 140 M can show how well Twist Bioscience Corp performed in making a profits. Evaluating Twist Bioscience income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Twist Bioscience's future profits or losses.
Cash Flow   Balance Sheet     Income Statement
 
Covid
Financial Statement Analysis is much more than just reviewing and examining Twist Bioscience Corp latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Twist Bioscience Corp is a good buy for the upcoming year.
  
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Twist Bioscience Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state.

About Twist Income Statement Analysis

Twist Bioscience Corp Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Twist Bioscience shareholders. The income statement also shows Twist investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).
Balance Sheet
Statement
Details
Cash Flow
Statement
Details
Financial
Indicators
Details
Valuation
Indicators
Details

Twist Bioscience Income Statement Chart

At this time, Twist Bioscience's Income Tax Expense is comparatively stable compared to the past year. Reconciled Depreciation is likely to gain to about 33 M in 2024, whereas Other Operating Expenses is likely to drop slightly above 283.1 M in 2024.
Selling General Administrative  Total Revenue  Other Operating Expenses  Research Development  Net Income Applicable To Common Shares  
Add Fundamental

Total Revenue

Total revenue comprises all receipts Twist Bioscience Corp generated from the sale of its products or services. The total amount of income generated by the sale of goods or services related to the company's primary operations.

Other Operating Expenses

Other Operating Expenses is the expense which generally does not depend on sales or production quantities of Twist Bioscience Corp. It is also known as Twist Bioscience overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.

Net Income Applicable To Common Shares

The net income that remains after preferred dividends have been deducted, available to common shareholders.
Most accounts from Twist Bioscience's income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Twist Bioscience Corp current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Twist Bioscience Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state.
At this time, Twist Bioscience's Income Tax Expense is comparatively stable compared to the past year. Reconciled Depreciation is likely to gain to about 33 M in 2024, whereas Other Operating Expenses is likely to drop slightly above 283.1 M in 2024.
 2021 2022 2023 2024 (projected)
Depreciation And Amortization2.0M29.3M31.4M33.0M
Interest Income3.1M14.4M15.3M16.1M

Twist Bioscience income statement Correlations

Net Interest Income
Interest Income
Depreciation And Amortization
Interest Expense
Selling General Administrative
Total Revenue
Gross Profit
Other Operating Expenses
Operating Income
Net Income From Continuing Ops
Ebit
Research Development
Ebitda
Cost Of Revenue
Total Operating Expenses
Income Before Tax
Total Other Income Expense Net
Net Income
Income Tax Expense
Reconciled Depreciation
Selling And Marketing Expenses
Non Operating Income Net Other
Non Recurring
Net Interest Income
1.00.96-0.750.730.920.910.77-0.78-0.8-0.760.69-0.680.930.75-0.790.75-0.80.050.980.810.84-0.76
Interest Income
1.00.96-0.710.710.910.90.76-0.77-0.79-0.740.66-0.670.920.73-0.770.73-0.790.080.980.790.83-0.77
Depreciation And Amortization
0.960.96-0.730.650.870.860.7-0.69-0.73-0.670.59-0.570.880.66-0.710.58-0.730.210.940.80.68-0.76
Interest Expense
-0.75-0.71-0.73-0.75-0.83-0.85-0.780.780.770.77-0.810.73-0.8-0.780.77-0.790.770.34-0.83-0.85-0.650.53
Selling General Administrative
0.730.710.65-0.750.90.890.99-0.97-0.96-0.960.97-0.950.91.0-0.960.84-0.96-0.50.80.90.59-0.37
Total Revenue
0.920.910.87-0.830.91.00.91-0.94-0.96-0.940.85-0.891.00.9-0.950.84-0.96-0.260.970.890.75-0.73
Gross Profit
0.910.90.86-0.850.891.00.9-0.93-0.95-0.930.85-0.880.990.89-0.940.84-0.95-0.280.960.890.75-0.74
Other Operating Expenses
0.770.760.7-0.780.990.910.9-0.96-0.95-0.940.97-0.930.911.0-0.950.84-0.95-0.440.840.930.63-0.39
Operating Income
-0.78-0.77-0.690.78-0.97-0.94-0.93-0.960.990.99-0.960.98-0.95-0.970.99-0.890.990.51-0.86-0.88-0.670.5
Net Income From Continuing Ops
-0.8-0.79-0.730.77-0.96-0.96-0.95-0.950.991.0-0.930.98-0.96-0.951.0-0.851.00.44-0.87-0.85-0.640.55
Ebit
-0.76-0.74-0.670.77-0.96-0.94-0.93-0.940.991.0-0.950.99-0.94-0.951.0-0.871.00.53-0.84-0.84-0.640.51
Research Development
0.690.660.59-0.810.970.850.850.97-0.96-0.93-0.95-0.950.860.98-0.940.88-0.93-0.590.780.890.61-0.29
Ebitda
-0.68-0.67-0.570.73-0.95-0.89-0.88-0.930.980.980.99-0.95-0.89-0.940.98-0.870.980.61-0.77-0.79-0.590.44
Cost Of Revenue
0.930.920.88-0.80.91.00.990.91-0.95-0.96-0.940.86-0.890.9-0.950.84-0.96-0.250.970.890.75-0.71
Total Operating Expenses
0.750.730.66-0.781.00.90.891.0-0.97-0.95-0.950.98-0.940.9-0.950.85-0.95-0.490.820.920.62-0.38
Income Before Tax
-0.79-0.77-0.710.77-0.96-0.95-0.94-0.950.991.01.0-0.940.98-0.95-0.95-0.861.00.47-0.86-0.85-0.640.54
Total Other Income Expense Net
0.750.730.58-0.790.840.840.840.84-0.89-0.85-0.870.88-0.870.840.85-0.86-0.85-0.570.820.750.88-0.48
Net Income
-0.8-0.79-0.730.77-0.96-0.96-0.95-0.950.991.01.0-0.930.98-0.96-0.951.0-0.850.44-0.87-0.85-0.640.55
Income Tax Expense
0.050.080.210.34-0.5-0.26-0.28-0.440.510.440.53-0.590.61-0.25-0.490.47-0.570.44-0.1-0.29-0.2-0.11
Reconciled Depreciation
0.980.980.94-0.830.80.970.960.84-0.86-0.87-0.840.78-0.770.970.82-0.860.82-0.87-0.10.870.84-0.75
Selling And Marketing Expenses
0.810.790.8-0.850.90.890.890.93-0.88-0.85-0.840.89-0.790.890.92-0.850.75-0.85-0.290.870.61-0.46
Non Operating Income Net Other
0.840.830.68-0.650.590.750.750.63-0.67-0.64-0.640.61-0.590.750.62-0.640.88-0.64-0.20.840.61-0.66
Non Recurring
-0.76-0.77-0.760.53-0.37-0.73-0.74-0.390.50.550.51-0.290.44-0.71-0.380.54-0.480.55-0.11-0.75-0.46-0.66
Click cells to compare fundamentals

Twist Bioscience Account Relationship Matchups

High Positive Relationship

Interest Income
+ 1.0
Net Interest Income
Total Operating Expenses
+ 1.0
Selling General Administrative
Gross Profit
+ 1.0
Total Revenue
Cost Of Revenue
+ 1.0
Total Revenue
Total Operating Expenses
+ 1.0
Other Operating Expenses
Ebit
+ 1.0
Net Income From Continuing Ops

High Negative Relationship

Total Operating Expenses
- 0.97
Operating Income
Operating Income
- 0.97
Selling General Administrative
Net Income
- 0.96
Cost Of Revenue
Cost Of Revenue
- 0.96
Net Income From Continuing Ops
Research Development
- 0.96
Operating Income
Operating Income
- 0.96
Other Operating Expenses

Twist Bioscience income statement Accounts

201920202021202220232024 (projected)
Tax Provision382K(1.9M)(10.4M)1.2M560K588K
Net Interest Income712K68K3.0M14.4M15.3M16.1M
Interest Income1.5M435K3.1M14.4M15.3M16.1M
Depreciation And Amortization6.7M12.0M2.0M29.3M31.4M33.0M
Interest Expense787K367K80K5K29K27.6K
Selling General Administrative102.1M133.4M210.5M186.8M218.4M124.4M
Total Revenue90.1M132.3M203.6M245.1M313.0M328.6M
Gross Profit28.7M51.7M84.2M89.7M133.3M140.0M
Other Operating Expenses207.7M285.6M452.6M462.3M533.8M283.1M
Operating Income(117.6M)(153.3M)(249.0M)(217.2M)(220.8M)(209.8M)
Net Income From Continuing Ops(139.9M)(152.1M)(217.9M)(204.6M)(208.7M)(219.2M)
Ebit(138.8M)(155.9M)(249.0M)(203.5M)(208.1M)(218.5M)
Research Development43.0M69.1M120.3M106.9M90.9M64.0M
Ebitda(132.1M)(143.9M)(247.0M)(174.2M)(176.7M)(185.5M)
Cost Of Revenue61.4M80.6M119.3M155.4M179.6M188.6M
Total Operating Expenses146.3M205.0M333.3M306.9M354.2M196.4M
Income Before Tax(139.5M)(154.0M)(228.3M)(203.5M)(208.2M)(218.6M)
Total Other Income Expense Net530K(1.3M)20.7M13.7M12.7M13.3M
Net Income Applicable To Common Shares(107.7M)(139.9M)(152.1M)(217.9M)(196.1M)(186.3M)
Net Income(139.9M)(152.1M)(217.9M)(204.6M)(208.7M)(219.2M)
Income Tax Expense382K(1.9M)(10.4M)1.2M560K588K
Reconciled Depreciation6.7M9.8M16.5M29.3M31.4M33.0M
Selling And Marketing Expenses1.2M2.5M2.4M2.9M3.3M2.3M

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Twist Stock Analysis

When running Twist Bioscience's price analysis, check to measure Twist Bioscience's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Twist Bioscience is operating at the current time. Most of Twist Bioscience's value examination focuses on studying past and present price action to predict the probability of Twist Bioscience's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Twist Bioscience's price. Additionally, you may evaluate how the addition of Twist Bioscience to your portfolios can decrease your overall portfolio volatility.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY